Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc B Garnick

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
How to interpret patient preferences in selecting the best drug: are the current measurements up to the job?Marc B Garnick
The New England Journal of Medicine|May 17, 2013
More on confusion of drug namesMarc B Garnick
The New England Journal of Medicine|January 11, 2013
Possible confusion in names of new treatments for prostate cancerMarc B Garnick
JAMA|May 26, 2018
Filling in the GapsMarc B Garnick
JAMA|December 16, 2014
Testosterone replacement therapy faces FDA scrutinyMarc B Garnick
JAMA|March 18, 2010
Screening and detection of breast cancer and prostate cancerMarc B Garnick
Annals of Internal Medicine|February 17, 2015
Rethinking the use of physicians as hired expert lecturersMarc B Garnick, Wendy Balter
BJU International|November 19, 2011
New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonistMarc B Garnick, Nicolas Mottet
Urology|January 23, 2026
Editorial Comment on "Tranexamic acid for the management of hematuria: A systematic reviewBoris Gershman, Marc B Garnick
European Urology|April 16, 2026
Considerations for Earlier Use of Radiopharmaceutical Therapy in Prostate CancerMarc B Garnick, Ken Herrmann,
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
How to interpret patient preferences in selecting the best drug: are the current measurements up to the job?Marc B Garnick
The New England Journal of Medicine|May 17, 2013
More on confusion of drug namesMarc B Garnick
The New England Journal of Medicine|January 11, 2013
Possible confusion in names of new treatments for prostate cancerMarc B Garnick
JAMA|May 26, 2018
Filling in the GapsMarc B Garnick
JAMA|December 16, 2014
Testosterone replacement therapy faces FDA scrutinyMarc B Garnick
JAMA|March 18, 2010
Screening and detection of breast cancer and prostate cancerMarc B Garnick
Annals of Internal Medicine|February 17, 2015
Rethinking the use of physicians as hired expert lecturersMarc B Garnick, Wendy Balter
BJU International|November 19, 2011
New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonistMarc B Garnick, Nicolas Mottet
Urology|January 23, 2026
Editorial Comment on "Tranexamic acid for the management of hematuria: A systematic reviewBoris Gershman, Marc B Garnick
European Urology|April 16, 2026
Considerations for Earlier Use of Radiopharmaceutical Therapy in Prostate CancerMarc B Garnick, Ken Herrmann,
Pageof 5